by Barbara Unger, FDAzilla GMP Quality Expert

INDIA | IMPORT ALERT 66-40 and Association with Warning Letters Regarding These Sites | Detention Without Physical Examination of Drugs from Firms Which Have Not Met Drug GMPs 

In this post, I consider the active import alerts in the “66-40” category currently posted on the FDA website for firms located in India and the frequency with which warning letters are associated with the import alerts. The tabulated data does not identify import alerts that may have been put in place and removed within this time period. Addresses are often difficult to unambiguously align, but I’ve made every attempt to do so. Where warning letters have been issued, most link(s) are provided. 

FROM THE FDA WEBSITE DESCRIBING IMPORT ALERT 66-40: “Foreign inspections of pharmaceutical manufacturers are being performed. Detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices (GMP’s).

Detention without physical examination (DWPE) may also be appropriate when the FDA receives information concerning inspections conducted by foreign or other government authorities under a Memorandum of Understanding or other agreement that reveals conditions or practices warranting detention of either particular products or of all products manufactured by a firm.

DWPE of such firms remains in effect until such time as the FDA is satisfied that the appearance of a violation has been removed, either by re-inspection or submission of appropriate documentation to the responsible FDA Center.

CONCLUSION:

  • Currently 41 sites in India are under import alert for failure to comply with GMPs (Table 3).
  • For these 41 sites, twenty-one of them, just under half do NOT have associated warning letters. Thus, being placed under import alert is no guarantee that a warning letter will be issued regarding the site nor is receiving a warning letter a guarantee of an import alert (Table 1).
  • Among the active import alerts in this category, four have been issued to a single company, one firm has 3 sites under import alert, nine (9) firms have two sites under import alert and sixteen (16) have a single site under import alert. The firm with four sites is Sun Pharmaceuticals, and this includes sites that Sun acquired in their purchase of Ranbaxy Pharmaceuticals (Table 2).
  • In three instances, EU reports of GMP non-compliance issued based on inspections in a similar timeframe. They are identified in Table 3 and summary reports may be found HERE.

TABLE 1:  Import Alerts per Calendar Year

YearNUMBER of AlertsImport Alerts With Associated Warning LettersImport Alerts Without Associated Warning Letters
2009220
2010000
2011624
2012000
20131459
2014871
20151147
2016000
TOTAL to 3/26/2016412021

 Figure 1.  Import Alerts by Year and Those Without Associated Warning Letters 

 TABLE 2: Active Import Alerts (66-40) per Company Site in India, 2009 – 2016 to date

COMPANYNUMBER of SITES
Sun Pharmaceuticals (includes sites that were previously Ranbaxy sites)4
Ipca Laboratories3
Wockhardt, RPG Life Sciences, Nivedita Chemicals, Flemming Laboratories, Vignesh Life Sciences, Apotex, Pan Drugs, Micro Labs, Aarti Drugs Limited2 sites for each firm

 

(9 companies, 18 total alerts)

Stericon, Yag Mag Labs, Amsal Chem Pvt Ltd, Smruthi Organics, Sentiss Pharma, Unique Chemicals, Kamud Drugs, Konduskar, Aadivighnesh Chem, Canton Laboratories, Marck Biosciences, Emcure Pharmaceuticals, Sri Krishna Pharmaceuticals, Akorn India, Polydrug Laboratories, Magafine Pharma1 site for each firm(16 total)

Table 3:  Listing of firms/sites in India currently under Import alert 66-40, by Date of Issue

Links are provided to associated warning letters on the FDA website

COMPANYSITEDATEOTHER
Sun Pharmaceutical (previously Ranbaxy)Village Ganguwala, Tehsil, Paonta Sahib, Simour District, Himachal Pradesh INDIA9/10/2009Archived
Sun Pharmaceutical (previously Ranbaxy)Industrial Area No. 3, Madhya Pradesh, Dewas, Madhya Pradesh INDIA9/10/2009Archived
Stericon Pharma Pvt. Ltd.No. 9, Sub Layout Of Plot 9, 1st Phase Bommasandra Ind. Area, Bangalore, Karnataka, INDIA1/13/2011Archived
Fleming Laboratories Ltd.Survey 270, Navabpet Village, Medak, Andhra Pradesh INDIA4/8/2011No warning letter posted. This site was the subject of a EU GMP report of non-compliance by the French authorities based on an inspection of October 11, 2013.
Fleming Laboratories LimitedPlot No. 48, Temple Rock Enclave, Tarbund X Road, Secunderabad, INDIA4/11/2011No warning letter posted
Yag Mag Labs Private LimitedSurvey No. 10, Gaddapotharam Village, Jinnatam Mandel, Medak District, AP, INDIA9/13/2011Archived
Nivedita Chemicals P lTdA14 MIDC Andheri East, Mumbai, IN-MH INDIA11/23/2011No warning letter posted
Nivedita Chemicals Pvt. Ltd.A-14 M.I.D.C. Andheri (East), Maharashtra, MS INDIA11/23/2011No warning letter posted
Amsal Chem Pvt. Ltd.A-1/401-402-403, GIDC, Ankleshwar, Gujarat, INDIA4/11/2013No warning letter posted
Wockhardt LimitedPlot H-14/2, Biotech Park, M.I.D.C. Area Waluj, Aurangabad, Maharashtra INDIA5/22/2013Warning Letter, July 18, 2013
Smruthi Organics LimitedPlot No. A-27, MIDC, Chincholi, Solapur District, Maharashtra, INDIA6/3/2013Warning Letter, March 6, 2014 This site was the subject of an EU GMP non-compliance report based on an inspection by authorities of the Netherlands, conducted on Oct 16, 2013.
RPG Life Sciences Limited25, M.I.D.C. Land, Thane-Belapur Road, Thane, Maharashtra INDIA6/10/2013Warning Letter, May 28, 2013
RPG Life Sciences Limited3102/A G.I.D.C. Estate, 393002, Ankleshwar, Gujarat INDIA6/11/2013Warning Letter, May 28, 2013
Sentiss Pharma Pvt. Ltd.Village Khera Nihla, Tehsil Nalargarh, District Solan, Himachal Pradesh INDIA6/20/2013No warning letter posted
Unique ChemicalsPlot P-10, Shiv Mahape Gansoli, Thane Belapur Road, Maharashtra State, Rabale, Maharashtra INDIA6/28/2013No warning letter posted
Vignesh Life Science Pvt Ltd202 Sarada Residency, H – 26, Madhura Nagar Ameerpet, Hyderabad, Tamil Nadu INDIA6/28/2013No warning letter posted
Vignesh Life Sciences Pvt., Ltd.93 & 94 P Mundargi Industrial Estate, Bellary Karnataka, INDIA6/28/2013No warning letter posted
Kamud Drugs Pvt. Ltd.N-608, MIDC, Kupwad, Sangli, M.S., INDIA7/10/2013No warning letter posted
Konduskar Laboratories Pvt LtdT-47 Kagel Hatkanangale Five Star, MIDC, Talandage (Village), Tal: Kagal,  Maharashtra State, INDIA7/10/2013No warning letter posted
Micro Labs LimitedPlot No. 113-116 4th Phase KIADB, Bommasandra Industrial Area, Anekal Taluk, Bangalore, INDIA8/21/2013No warning Letter posted
Sun Pharmaceutical Industries (prev. Ranbaxy)SEZ Unit 1, Plot No. A-41, Industrial Area Phase VIII-A, SAS Nagar, Mohali, Punjab INDIA. This site and data are listed twice on the FDA site but are listed here only once.9/13/2013No warning letter posted
Wockhardt LimitedL-1, MIDC Area, Jalgaon Road 43, Chikalthana, Aurangabad, Maharashtra INDIA11/26/213Warning Letter, November 25, 2013
Marck Biosciences Ltd.Plot No. 876, N.H. – 8, Vill: Hariyala, Tal: Matar, Kheda, Gujarat INDIA3/12/2014Archived
Sun Pharmaceutical Industries Limited – KarkhadiPlot No. 817/A, Village – Karkhadi, Taluka – Padra District, Vadodara, Gujarat, INDIA3/12/2014Warning Letter, May 7, 2014
Ipca Laboratories Ltd1 Pharma Zone, Pithampur, Madhya Pradesh INDIA3/25/2014Warning Letter, Jan 29, 2016
Apotex Pharmachem India Pvt Ltd.Plot No.: 1A, Bommasandra, Industrial Area, 4th Phase, Bangalore, INDIA4/1/2014Warning Letter, June 16, 2014
Canton Laboratories Pvt. Ltd.110 A & B Gidc Estate, Makarpura Road; M I Estate, Vadodara, Gujarat INDIA4/10/2014Warning Letter, February 27, 2014
Aadivighnesh Chem PVT. LTD.A/7 Badrinath Apartment, Simpoli Road, Borivali (West), Mumbai, Maharashtra INDIA5/5/2014No warning letter posted
Micro Labs LimitedS – 155 Plot No, Verna Industrial Estate, Vasco Da Gama, Goa INDIA9/19/2014Warning Letter, January 9, 2015
Apotex Research Private LimitedPlot 1/2, Site #2 Bommasandra Ind. Area, 4th Phase, Jigani Link Rd., Jigani Hobli, Bangalore, Karnataka State INDIA9/22/2014Warning Letter, January 30, 2015
Ipca Laboratories LimitedVillage Sejavta, Ratlam, Madhya Pradesh INDIA1/22/2015Warning Letter, Jan 29, 2016
Aarti Drugs LimitedPlot No. E-22, M.I.D.C., Tarapur, Palghar, Maharashtra INDIA3/23/2015Only Warning Letter is a previous one dated July 30, 2013
Aarti Drugs LimitedG-60 Boisar MIDC Tarapur, Tal. Palghar, District Thane, Tarapur, Maharashtra INDIA3/23/2015Only Warning Letter is a previous one dated July 30, 2013
Ipca Laboratories Ltd1 Pharma Zone, Pithampur, Madhya Pradesh INDIA3/24/2015Warning Letter, Jan 29, 2016
Ipca Laboratories LtdPlot No. 65 and 99, Danudyog, Ind. Estate, Piparia, Silvasa (D and NH), INDIA3/24/2015Warning Letter, Jan 29, 2016
Pan Drugs Ltd.167-168, GIDC Nandesari Ind. Estate, Nandesari, Vadodara, Gujarat INDIA5/5/2015Warning Letter, September 2, 2015
Emcure Pharmaceuticals LimitedPlot No. P-1 & P-2, IT-BT Park Phase II, MIDC, Hinjwadi, Hinjwadi, Pune, Maharashtra INDIA7/13/2015Warning Letter, March 3, 2016,
Sri Krishna Pharmaceuticals Ltd. – Unit IIA-35, IDA, Nacharam, Hyderabad, Andhra Pradesh, INDIA8/13/2015No warning letter posted. An EU Summary Report of Non-compliance was issued based on an inspection of December 4, 2014 conducted by Italian authorities.
Akorn India PVTKhasra 5/1, 5/2, 5/3 Village, Nihalgarth Tehsil, Paonta Sahib, Simour, Himachal Pradesh INDIA8/21/2015No warning letter posted
Polydrug Laboratories Pvt. Ltd.Plot N37, Ambernath Industrial Area, Anand Nagar MIDC, Mumbai, Maharashtra INDIA9/11/2015No warning letter posted
Megafine Pharma (P) Limited48 – 51/201 Plot No 31 – 35, Lakhamapur, Maharashtra INDIA10/14/2015No warning letter posted
Pan Drugs Limited192 G I D C Makarpura Industrial Estate, M I Estate, Vadodara, Gujarat INDIA12/08/2015No warning letter posted

Comparing and Analyzing Russian, UK, and US Top Ten Pharma Inspection Findings FY 2019

Webinar: Comparing and Analyzing Russian, UK, and US Top Ten Pharma Inspection Findings FY 2019

Presented by Jerry Chapman on October 29, 2020

What you will learn:

  • A comparison of 483 observations in FY2019
  • Top 10 Russian Ministry of Health inspection findings
  • Top 10 FDA Warning Letter findings
  • Top MHRA inspection findings
Redica Systems Enforcement Analytics

Get help choosing the right CRO.

Enter your email address and someone will contact you shortly to customize your insights.

Experience the Power of Redica Systems

Complete the form and one of our experts will reach out to you to schedule a demo and answer questions about our subscription options.

INDEX INFORMATION  Redica consolidates regulatory data in real-time on the single largest database for quality, safety, and compliance intelligence.

STRENGTHEN DATASETS Redica machine intelligence algorithms identify and triage risk signals to derive meaning from vast amounts of private and public data.

ANALYZE & INTERPRET PATTERNS Redica instantly models the customer-specific regulatory risks, trends, and opportunities that stand to fundamentally change compliance operations.

Redica Systems Enforcement Analytics

Evaluate Your CDMOs

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Compare the inspection history of your CDMO sites.

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Compare the enforcement history of your CDMOs.

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Monitor compliance at your Clinical Investigator sites.

Enter your email address and someone will contact you shortly to get you started.

Redica Systems Enforcement Analytics

Prepare for inspections of Clinical Investigator sites.

Enter your email address and someone will contact you shortly to provide more Clinical Investigator data about your sites.

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore enforcement trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore observations and trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to run your custom report.

Redica Systems Enforcement Analytics

Compare two companies of your choice.

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Download the Special Report

Download your copy of THE FDA INSPECTION LANDSCAPE IN MID-2020 AND A LOOK AT VIRTUAL INSPECTION

In this summary we identify:

  • Trend analysis of FDA inspections through mid-2020
  • Strategies for preparing and hosting virtual inspections
  • New technologies to support remote inspections

Download the Special Report

CDMO Comparison opt-in

In this summary we identify:

FY2018-FY2020 GMP data for Lonza & Catalent

Top GMP primary citations

Top FDA 483 observations

Panel Discussion – Remote Audits

Panel Discussion opt in image

Featuring Panelists:
—Barbara W. Unger, Unger Consulting, Inc.
—Jerry Chapman, Redica Systems
—Stephanie Gaulding, Pharmatech Associates

Who Will Benefit?
This session will be valuable to GMP quality, regulatory, compliance, and management personnel in FDA-regulated industries who want to have a conversation on remote audits and get to know what is going on in the industry.

Turning Failure into Success

Presented on Tuesday, April 27, 2021 by Steve Greer, Executive Coach, Genesis Assist, and former Quality Leader, Procter and Gamble

What you will learn:

  • How to use the Leadership SOS Model to transform quality culture
  • How to strengthen quality systems to eliminate human error
  • How to generate ideas on how to set your organization up for success for shareholders, FDA, and staff
Redica Systems Enforcement Analytics

Get Full Access to Redica Enforcement Analytics

Enter your email address and someone will contact you shortly to answer all of your questions and get you started.

Quality Management Systems for Small Pharma and Biotech Firms

Webinar: QMS for Small Pharma and Biotech Firms

Presented by Fenton Fong, Founder, Managing Director, & Principal at xCellarate

Get instant access to the webinar video and slides.

What you will learn:

  • Common challenges small pharma firms face when developing a QMS
    Recent enforcement trends involving the Quality Unit
    Impact of the COVID-19 pandemic

Download the Special Report

APAC ad

In this summary we identify:

GMP data from FY2017 to FY2020 for the Asia-Pacific region

Top 3 GMP primary and secondary citations

Top 3 483 observations

Download the Special Report

An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

In this summary we identify:

  • Data from 2019 UK MHRA Inspections
  • Trends from 2015, 2016, 2018, and 2019 inspections
  • Conclusions drawn from an analysis of drug inspection data

Experience the Power of Redica Systems

Redica Systems

SEARCH Find the inspection records you want by inspector’s name, company name, site, city, country, etc.

WARNING LETTERS Easily search the largest database of FDA Warning Letters by date, company, FDA office, or subject

SITES Quickly assess inspection records including dates and inspectors across all of your sites

INSPECTIONS Complete list of FDA inspections by date, company, category, and country

Get Complete Access to the Redica Systems Platform

Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need to prepare for your next inspection.

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Sign up for your FREE account today and get instant access to Enforcement Analytics.

Champion of Change - 3Cs to Success

Webinar: Champion of Change - 3Cs to Success

Presented by Steve Greer on June 23, 2020

What you will learn:

  • The 3C Model to become a champion of change
  • How to identify game-changing habits and the steps to implement them
  • Ways to develop greater purpose-centered leadership
  • How to generate awareness along with actions to create changes in how you think about challenges and change putting you on a path to lead change successfully in your organization
  •  

Download the Special Report

5 GMP Case Studies Report

What You Will Learn from This Report:

The first countrywide import alert issued by FDA

An inadequate deviation investigation

An inadequate product specifications and a product recall

Process validation issues at a CMO

A different perspective on process validation and the culpability of the quality unit

 

Download the Special Report

Quality Week report sidebar

What You Will Learn from This Report:

How a major pharmaceutical company designed a program to train future leaders in quality

An industry-led initiative to advance the state of quality in the pharma industry

A pharma GMP leader’s tips for supporting quality culture within an organization

An update on FDA’s Quality Maturity Model

Impact of the Global Pandemic on Recent Data Integrity and Regulatory Non-compliance Trends

Webinar: Impact of the Global Pandemic on Recent Data Integrity and Regulatory Non-compliance Trends

Presented by Paul Smith, Agilent Technologies on Aug. 26, 2020

What you will learn:

  • Examples of essential laboratory actions to remain compliant during the pandemic
  • Recent data integrity non-compliance findings and trends
  • Essential strategies to find, understand, and leverage regulatory non-compliance data

Past, Present, and Future of Quality Culture

Presented by Regulatory Compliance Associates Distinguished Fellow Susan Schniepp

What you will learn:

  • How the 2014 FDA quality metrics initiative led to greater focus on quality culture
  • New quality culture tools and standards under development by PDA and other organizations
  • Best practices for quality culture, including case studies with lessons learned

Changing Medical Device Regulations

Presented by Redica Systems 

What you will learn:

  • The latest developments regarding the EU MDR
  • Quality Systems requirements for medical devices
  • Regulatory updates affecting medical devices

Download the Special Report

Combination Product Report

What You Will Learn from This Report:

The latest U.S. and European regulatory developments

The impact of smart combination products

How the EU MDR impacts drug-device combination products

Download the Special Report

5 GMP Case Studies Report

What You Will Learn from This Report:

In-depth analysis of the findings

Lessons learned

How companies can avoid similar shortcomings.

Experience the Power of Redica Systems

Redica Systems Expert Jerry Chapman to Present at SQA Annual Meeting

Index Information Redica consolidates regulatory data in real-time on the single largest database for quality, safety, and compliance intelligence.

Strengthen Datasets Redica machine intelligence algorithms identify and triage risk signals to derive meaning from vast amounts of private and public data.

Analyze & Interpret Patterns Redica instantly models the customer-specific regulatory risks, trends, and opportunities that stand to fundamentally change compliance operations.

Download the 510(k) Sample

What You Will Learn from This Sample:

See how a 510(k) submission is structured

Find out what information to include

Review correspondence between sponsor and FDA

Redica Systems Enforcement Analytics

Unlimited Access to Reports and Data

Enter your email address and someone will contact you shortly.

A.I. for Quality and Compliance Teams

August 3 webinar

Presented by Redica Systems Senior GMP Quality Expert Jerry Chapman

What you will learn:

  • A basic understanding of data sources, machine learning, NLP, and A.I. tools
  • Building and applying Expert Models
  • Two case studies, one on sterile manufacturing/503B and one on data integrity
Redica Systems Enforcement Analytics

Upgrade your CDMO management strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Get the scoop on recent data integrity 483 observations!

  • FY 2020 Data Integrity 483 Observations
  • Data Integrity Observations for Human Drugs
  • Observations Falling Under GMP
  •  

Human Factors – Compliance and Applications

June webinar

Presented by Alison Sathe, Founder, Regulatory Mark & Valerie Fenster, Director of Insights and  Human Factors, Kaleidoscope Innovation 

What you will learn:

  • Human factors strategies from simple drug products to complex surgical devices
  • Primary and secondary labeling development and evaluation for usability
  • Human factors activities from product development to post-market
  • International strategies: expectations for human factors in regulatory submissions in international markets

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Let us know who you are and we’ll be in touch to answer all of your questions and get you started.

Redica Systems Enforcement Analytics

Keep up with the latest Regulatory Developments on Clinical Trials

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Save your team valuable time when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Save time and Resources when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Get immediate access to the news that matters to your sites.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

See how we can help you eliminate yet another spreadsheet.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Stay ahead of changing regulations.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Redica Systems Enforcement Analytics

Upgrade your CDMO monitoring strategy.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Discover the power of the most comprehensive database of 483s in existence.

Our database of over 20,000 483s is retyped and tagged, making it easy to create an Observation Report in seconds.

Eliminate days of work and get your FREE personalized 483 Observation Report.